HomeDOSE • CNSX
add
Rapid Dose Therapeutics Corp
Previous close
$0.13
Year range
$0.13 - $0.24
Market cap
17.58M CAD
Avg Volume
23.03K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Aug 2025info | Y/Y change |
|---|---|---|
Revenue | 672.92K | 30.43% |
Operating expense | 919.24K | -22.46% |
Net income | -825.47K | 24.93% |
Net profit margin | -122.67 | 42.45% |
Earnings per share | — | — |
EBITDA | -501.96K | 37.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Aug 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.57K | -88.04% |
Total assets | 4.25M | 147.49% |
Total liabilities | 10.13M | 85.13% |
Total equity | -5.88M | — |
Shares outstanding | 132.87M | — |
Price to book | -3.25 | — |
Return on assets | -32.93% | — |
Return on capital | 462.33% | — |
Cash Flow
Net change in cash
| (CAD) | Aug 2025info | Y/Y change |
|---|---|---|
Net income | -825.47K | 24.93% |
Cash from operations | -262.01K | -0.27% |
Cash from investing | — | — |
Cash from financing | 262.01K | 19.13% |
Net change in cash | -63.30K | -52.95% |
Free cash flow | 43.87K | 161.61% |
About
Founded
2008
Headquarters
Website
